Federation Des Caisses Desjardins Du Quebec Valneva Se Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.4 Billion
Q4 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$6.64 - $10.76 $1,328 - $2,152	200 New	200 $1.58 Million
Q1 2022 Aug 14, 2024	BUY	$27.0 - $50.99 $5,400 - $10,198	200 New	200 $6.86 Million
Q3 2021 Aug 30, 2024	BUY	$25.02 - $53.38 $5,004 - $10,676	200 New	200 $6.28 Million

Others Institutions Holding VALN

# of Institutions

Shares Held

719K

Call Options Held

Put Options Held

General American Investors CO Inc

354K
Shares

$2.53 Million
0.11% of portfolio
Wells Fargo & Company San Francisco, CA

247K
Shares

$1.76 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

69.5K
Shares

$496,215
0.0% of portfolio
Ironwood Investment Management LLC Boston, MA

25K
Shares

$178,657
0.06% of portfolio
Abc Arbitrage Sa Paris, I0

19.2K
Shares

$137,402
0.01% of portfolio

View Full List

About Valneva SE

Ticker VALN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,103,504
Market Cap $493M
Description
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...

More about VALN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account